Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...
The offseason appears to be winding down, with Framber Valdez being the only marquee free agent remaining, but Chris Towers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results